These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7135352)

  • 21. Comparison of pathological clotting using haematological, functional and morphological investigations in HIV-positive and HIV-negative patients with deep vein thrombosis.
    Jackson BS; Nunes Goncalves J; Pretorius E
    Retrovirology; 2020 Jun; 17(1):14. PubMed ID: 32571345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markers of plasma coagulation and fibrinolysis after acute deep venous thrombosis.
    Meissner MH; Zierler BK; Bergelin RO; Chandler WC; Manzo RA; Strandness DE
    J Vasc Surg; 2000 Nov; 32(5):870-80. PubMed ID: 11054218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis.
    Gschwandtner ME; Eichinger S; Hütter D; Korninger L; Lechner K; Panzer S; Pabinger I
    Blood Coagul Fibrinolysis; 1996 Apr; 7(3):325-30. PubMed ID: 8735139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemostatic changes in patients with deep vein thrombosis.
    Trifiletti A; Scamardi R; Pizzoleo MA; Soraci S; Nevoso A; Bagnato L; Barbera N
    Panminerva Med; 1997 Mar; 39(1):21-3. PubMed ID: 9175416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term blood abnormalities in thrombosis.
    Lancet; 1973 Jul; 2(7821):133-4. PubMed ID: 4124048
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma concentrations of fibrinopeptide A, fibrinogen fragment B beta 1-42 and beta-thromboglobulin following total hip replacement.
    Lane DA; Ireland H; Wolff S; Grant R; Jennings S; Allen-Mersh T
    Thromb Res; 1982 Apr; 26(2):111-8. PubMed ID: 6180501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood coagulation during adjuvant epirubicin/cyclophosphamide chemotherapy in patients with primary operable breast cancer.
    von Tempelhoff GF; Dietrich M; Hommel G; Heilmann L
    J Clin Oncol; 1996 Sep; 14(9):2560-8. PubMed ID: 8823336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of hypercoagulability in patients with cancer using the Sonoclot Analyzer and thromboelastography.
    Francis JL; Francis DA; Gunathilagan GJ
    Thromb Res; 1994 May; 74(4):335-46. PubMed ID: 8085235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinopeptide A, beta-thromboglobulin, and fibrin degradation products as screening test for the diagnosis of deep vein thrombosis.
    Wojciechowski J; Olausson M; Korsan-Bengtsen K
    Haemostasis; 1983; 13(4):254-61. PubMed ID: 6194049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Procedure-dependence and tissue factor-independence of hypercoagulability during orthopaedic surgery.
    Fedi S; Gori AM; Falciani M; Cellai AP; Aglietti P; Baldini A; Vena LM; Prisco D; Abbate R; Gensini GF
    Thromb Haemost; 1999 Jun; 81(6):874-8. PubMed ID: 10404760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies on the pathogenesis of hypercoagulability in patients with arterial thrombosis and malignancy].
    Uchiyama T; Andoh K; Tanaka H; Kobayashi N; Naruse T; Maekawa T
    Rinsho Byori; 1990 Jul; Suppl 86():125-33. PubMed ID: 2232233
    [No Abstract]   [Full Text] [Related]  

  • 32. Persistent hypercoagulation associated with heterotopic ossification in patients with spinal cord injury long after injury has occurred.
    Perkash A; Sullivan G; Toth L; Bradleigh LH; Linder SH; Perkash I
    Paraplegia; 1993 Oct; 31(10):653-9. PubMed ID: 8259328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Coagulation and fibrinolysis proteins in nephrotic syndromes in children].
    Loirat C; Pillion G; Schlegel N; Douenias R; Mathieu H
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LVI-LXIII. PubMed ID: 539878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. beta-thromboglobulin and heparin-neutralising activity test in clinical conditions.
    Lancet; 1977 May; 1(8022):1153-4. PubMed ID: 68249
    [No Abstract]   [Full Text] [Related]  

  • 35. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS).
    Koster T; Rosendaal FR; Reitsma PH; van der Velden PA; Briët E; Vandenbroucke JP
    Thromb Haemost; 1994 Jun; 71(6):719-22. PubMed ID: 7974338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tests for hemostasis and their relevance to venous thrombosis.
    Johnston DW; Scott AA; Glynn MF
    Can J Surg; 1980 Jul; 23(4):373-80. PubMed ID: 6968239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
    Dempfle CE; Kälsch T; Elmas E; Suvajac N; Lücke T; Münch E; Borggrefe M
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):765-70. PubMed ID: 19002042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assay of antithrombin III and soluble fibrin complexes in the study of blood thrombophilia (author's transl)].
    Colombo LA; Corberi OM; Finzi M; Rossi G
    Chir Ital; 1979 Aug; 31(4):650-61. PubMed ID: 553732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypercoagulability. Should every patient with venous thrombosis be tested?
    Freed JA
    Postgrad Med; 1991 Nov; 90(6):157-60, 165-6, 168. PubMed ID: 1946109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hypercoagulable states.
    Schafer AI
    Ann Intern Med; 1985 Jun; 102(6):814-28. PubMed ID: 3158262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.